Abstract:Introduction Diabetic nephropathy is the leading cause of endstage renal disease worldwide and a leading cause of morbidity and mortality in diabetic patient. There is growing evidence that abnormal lipid metabolism and renal accumulation of lipids play a role in the pathogenesis of diabetic nephropathy (1-3). Kidney biopsy and histological analysis is not ideal for longitudinal follow-up studies. Proton (H) magnetic resonance (MR) imaging offers several non-invasive methods to obtain separate fat and water images, allowing for obtaining the fat-to-water ratio in tissues and quantifying the fat content. Sbarbati et al. applied chemical shift imaging (CSI) to quantify lipid in the brown adipose tissue in vivo (4). MR measurements of fat contents in the liver, skeletal muscle, pancreas and heart in vivo have been studied (58). However, to our knowledge, this non-invasive approach has not yet been applied and investigated for measuring the lipid accumulation in kidney. The purpose of this study was to study the feasibility and accuracy of in vivo MR measurement of lipid accumulation in kidney using the diabetes (db/db) mouse model. Methods All animal experiments were approved by the institutional Committee on Animal Research. Fifteen-week-old C57BLKS/J db/db and wild type (WT) mice (n=10) with an average weight of 51.63 ± 1.89 g and 31.38 ± 1.44 g were used in this study. Phantoms were made according to the volume percentage of fat ranging from 0% to 100%. All MR experiments were carried out using a 7.0 T small animal magnetic resonance system (Bruker PharmaScan, Ettlingen, Germany). CSI were performed to measure lipid contents (LCs) in phantoms, kidneys of mice. The results were compared to known LCs in phantoms and to the reference standard from mice by kidney lipid (KL) chemical analysis. T1WI was performed to estimate adipose tissue distribution of visceral (VS) and subcutaneous (SC) of mice. Results CSI underestimated fat concentration when FC was in range of 50% to 100%. Full details about imaging phantoms were described in our previous study (5). In vivo, the averaged LCCSI of the renal cortex and medulla in db/db mice were 12.73±0.94% and 6.46±1.02%, respectively. In comparison, the averaged LCCSI of renal cortex and medulla in WT mice were 3.16±0.50% and 2.67±0.70%. Significant differences in kidney LC in renal cortex and renal medulla between the db/db mice and WT mice were observed using the data from CSI (P<0.01). Interestingly, the Kidney LC in renal medulla of db/db mice is low than that in the renal cortex (P<0.01), but no significant difference between the renal cortex and medulla was found in WT mice (P=0.068). The averaged KL in db/db mice calculated by the chemical analysis method was higher than that of WT mice with 9.22±1.44mg and 4.11±0.74mg, respectively. A strong correlation between the averaged KL measured by the chemical method and the LC calculated by the MR method (r=0.916, P=0.000) was observed. Visceral fat of the total amount of white adipose tissue in db/db mice was significantly higher than that of WT mice. In the kidney sections of db/db mice examined by the oil-red O staining, lipids were found accumulated in the glomeruli and proximal tubules of the renal cortex, but not in the WT mice.

Comparison of Local Metabolic Changes in Diabetic Rodent Kidneys Using Mass Spectrometry Imaging

Systemic Perturbations Of Key Metabolites In Diabetic Rats During The Evolution Of Diabetes Studied By Urine Metabonomics

Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging

¹H-Nmr-based Metabonomic Analysis of Metabolic Profiling in Diabetic Nephropathy Rats Induced by Streptozotocin.

In Situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease

Metabolite aberrations in early diabetes detected in rat kidney using mass spectrometry imaging

Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using high-resolution magic-angle spinning 1 H NMR spectroscopy

Gc/Tofms Analysis of Metabolites in Serum and Urine Reveals Metabolic Perturbation of Tca Cycle in Db/Db Mice Involved in Diabetic Nephropathy

Altered retinoic acid metabolism in diabetic mouse kidney identified by O isotopic labeling and 2D mass spectrometry

1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy.

Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin.

1 H NMR-based Metabonomic Analysis of Metabolic Changes in Streptozotocin-induced Diabetic Rats

Changes In Hepatic Metabolic Profile During The Evolution Of Stz-Induced Diabetic Rats Via An H-1 Nmr-Based Metabonomic Investigation

In vivo quantification of renal lipid in diabetic mice by magnetic resonance imaging

A metabonomic comparison of urinary changes in Zucker and GK rats.

Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications

1H NMR-Based Metabonomics Study of Urine and Serum Samples from Diabetic Db/db Mice

Spatial localization of β-unsaturated aldehyde markers in murine diabetic kidney tissue by mass spectrometry imaging

Spatially Resolved Metabolomics Based on Air-Flow-Assisted Desorption Electrospray Ionization-Mass Spectrometry Imaging Reveals Region-Specific Metabolic Alterations in Diabetic Encephalopathy

Non-invasive detection of divergent metabolic signals in insulin deficiency vs. insulin resistance in vivo

400-P: Spatial Metabolomics Analysis by MSI-DeepPath Identifies Key Pathways in ZDF Diabetic Kidney Disease Model